共 10 条
[1]
Blockade of platelet GP Ⅱb /Ⅲa receptor as an antithrombotic strategy. Coller BS. Circulation . 1995
[2]
Pharmacology of GP Ⅱb /Ⅲa platelet inhibition, part IV. Talley JD. J of Interven Cardiol . 2000
[3]
A critical appraisal of platelet glycoproteinⅡb /Ⅲa lnhibition. Chew DP,Moliterno DJ. Journalism Assn of Community College . 2000
[4]
Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. The CAPTURE investigator. The Lancet . 1997
[5]
Abciximab reduces mortality in diabetics following percutaneous coronary intervention. Bhatt DL,Marso SP,Lincoff AM,et al. Journalism Assn of Community College . 2000
[6]
inhibition of platelet glycoprotein Ⅱb /Ⅲa with eptifibatide in patients with acute coronary syndrome. PURSUIT tial investgator. The New England Journal of Medicine . 1998
[7]
Use of a monoclonal antibody directed against the platelet glycoprotein Ⅱb /Ⅲa receptor in high-risk coronary angioplasty. The EPIC investigator. The New England Journal of Medicine . 1994
[8]
A randomized placebocontrolled trial of platelet glycoprotein Ⅱb /Ⅲa blockade with primary angioplasty for acute myocardial infarction. Brener SJ,Bars LA,Burchenal JEB,et al. Circulation . 1998
[9]
Platelet glycoprotein Ⅱb /Ⅲa receptor blockade in coronary artery disease. Lincoff AM,Califf RM,Topol EJ. Journalism Assn of Community College . 2000
[10]
effect of platelet glycoprotein Ⅱb /Ⅲa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. RESTORE investigator. Circulation . 1997